These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33906125)

  • 21. SARS-CoV-2 immunity in animal models.
    Chen Z; Yuan Y; Hu Q; Zhu A; Chen F; Li S; Guan X; Lv C; Tang T; He Y; Cheng J; Zheng J; Hu X; Zhao J; Zhao J; Sun J
    Cell Mol Immunol; 2024 Feb; 21(2):119-133. PubMed ID: 38238440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
    Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
    mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries.
    Marian AJ
    Cardiovasc Pathol; 2021; 50():107278. PubMed ID: 32889088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models.
    Kim YI; Casel MAB; Choi YK
    J Microbiol; 2022 Mar; 60(3):255-267. PubMed ID: 35235177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of SARS-CoV-2 animal vaccines using a stable and efficient NDV expression system.
    He L; Zhong J; Li G; Lin Z; Zhao P; Yang C; Wang H; Zhang Y; Yang X; Wang Z
    J Med Virol; 2023 Jan; 95(1):e28237. PubMed ID: 36258299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental Animal Models of Coronavirus Infections: Strengths and Limitations.
    Casel MAB; Rollon RG; Choi YK
    Immune Netw; 2021 Apr; 21(2):e12. PubMed ID: 33996168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists.
    Yuen E; Gudis DA; Rowan NR; Nguyen SA; Schlosser RJ
    Am J Rhinol Allergy; 2021 Jan; 35(1):122-131. PubMed ID: 32762250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge.
    Winkler MS; Skirecki T; Brunkhorst FM; Cajander S; Cavaillon JM; Ferrer R; Flohé SB; García-Salido A; Giamarellos-Bourboulis EJ; Girardis M; Kox M; Lachmann G; Martin-Loeches I; Netea MG; Spinetti T; Schefold JC; Torres A; Uhle F; Venet F; Weis S; Scherag A; Rubio I; Osuchowski MF
    EBioMedicine; 2021 Apr; 66():103291. PubMed ID: 33813139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines-Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials.
    Buchman TG; Draghia-Akli R; Adam SJ; Aggarwal NR; Fessel JP; Higgs ES; Menetski JP; Read SW; Hughes EA;
    Crit Care Med; 2021 Nov; 49(11):1963-1973. PubMed ID: 34495876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects.
    Arashkia A; Jalilvand S; Mohajel N; Afchangi A; Azadmanesh K; Salehi-Vaziri M; Fazlalipour M; Pouriayevali MH; Jalali T; Mousavi Nasab SD; Roohvand F; Shoja Z;
    Rev Med Virol; 2021 May; 31(3):e2183. PubMed ID: 33594794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.
    Tostanoski LH; Wegmann F; Martinot AJ; Loos C; McMahan K; Mercado NB; Yu J; Chan CN; Bondoc S; Starke CE; Nekorchuk M; Busman-Sahay K; Piedra-Mora C; Wrijil LM; Ducat S; Custers J; Atyeo C; Fischinger S; Burke JS; Feldman J; Hauser BM; Caradonna TM; Bondzie EA; Dagotto G; Gebre MS; Jacob-Dolan C; Lin Z; Mahrokhian SH; Nampanya F; Nityanandam R; Pessaint L; Porto M; Ali V; Benetiene D; Tevi K; Andersen H; Lewis MG; Schmidt AG; Lauffenburger DA; Alter G; Estes JD; Schuitemaker H; Zahn R; Barouch DH
    Nat Med; 2020 Nov; 26(11):1694-1700. PubMed ID: 32884153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe acute respiratory syndrome coronavirus-2 natural animal reservoirs and experimental models: systematic review.
    Younes S; Younes N; Shurrab F; Nasrallah GK
    Rev Med Virol; 2021 Jul; 31(4):e2196. PubMed ID: 33206434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
    Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 basics and vaccine development with a Canadian perspective.
    Liu M; Chen X
    Can J Microbiol; 2021 Feb; 67(2):112-118. PubMed ID: 33136431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2).
    Beeraka NM; Tulimilli SV; Karnik M; Sadhu SP; Pragada RR; Aliev G; Madhunapantula SV
    Biomed Res Int; 2021; 2021():8160860. PubMed ID: 34159203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.
    Forchette L; Sebastian W; Liu T
    Curr Med Sci; 2021 Dec; 41(6):1037-1051. PubMed ID: 34241776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternatives to animal models and their application in the discovery of species susceptibility to SARS-CoV-2 and other respiratory infectious pathogens: A review.
    Runft S; Färber I; Krüger J; Krüger N; Armando F; Rocha C; Pöhlmann S; Burigk L; Leitzen E; Ciurkiewicz M; Braun A; Schneider D; Baumgärtner L; Freisleben B; Baumgärtner W
    Vet Pathol; 2022 Jul; 59(4):565-577. PubMed ID: 35130766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks.
    Cao M; Su X; Jiang S
    Stem Cell Reports; 2021 Mar; 16(3):398-411. PubMed ID: 33691145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.